RS:NYSEReliance, Inc. Analysis
Data as of 2026-08-31 - not real-time
$385.31
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Reliance, Inc. trades at $385.31, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. With RSI at 40.2 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $379.86 and resistance at $433.02.
Multiples put this in fair territory at a P/E of 22.4. Consensus targets land 6.1% above where the shares trade now. Revenue is growing at 26.5% on a 5.7% profit margin. The 1.29% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 30.7%, a beta of 0.65 and a maximum drawdown of 19.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.
Multiples put this in fair territory at a P/E of 22.4. Consensus targets land 6.1% above where the shares trade now. Revenue is growing at 26.5% on a 5.7% profit margin. The 1.29% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 30.7%, a beta of 0.65 and a maximum drawdown of 19.4%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.
Top Market Events
Kalkine Media6dWhy Is Reliance NYSE:RS in Focus After Stronger Shipments?
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 344.21
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 344.21
- Analyst targets imply +6.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Analyst targets imply +6.1% versus the current price
- Revenue growth of +26.5%
- P/E ratio of 22.4
Key Metrics & Analysis
Financial Health
Revenue Growth26.50%
Profit Margin5.66%
P/E Ratio22.4
ROE12.23%
ROA7.33%
Debt/Equity26.92
P/B Ratio2.7
Op. Cash Flow$851.5M
Free Cash Flow$345.4M
Technical Analysis
TrendBullish
RSI40.2
Support$379.86
Resistance$433.02
MA 20$407.38
MA 50$397.55
MA 200$344.21
MACDBearish
VolumeIncreasing
Fear & Greed Index94.32
Valuation
Fair Value$202.54
Target Price$408.63
Upside/Downside6.05%
GradeFair
TypeBlend
Dividend Yield1.29%
Risk Assessment
Beta0.65
Volatility30.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.